GeneGlobe ID: PHS-3200Z | Cat. No.: | QIAseq Targeted DNA Pro Panels

QIAseq Targeted DNA Pro Human Comprehensive Hereditary Cancer Research Panel

Kit containing ALL reagents (except indexes) for targeted DNA sequencing

Select a variant to see the price

Product Specification

Target List

Covers all exons in all known transcripts of targeted genes based on the Human GRCh38 genome build

Central Nervous System Cancers
Anaplastic Glial Tumors​
CDKN2A (P16INK4A)CDKN2B (p15INK4b)PTENRB1TP53 (p53)
Astrocytomas​
APCATRXBRAFCDKN2A (P16INK4A)CDKN2B (p15INK4b)CDKN2B-AS1CHEK2 (RAD53)FGFR1HIPK2HRASIDH1MSH2MYBNF1PALB2PTPN11RB1SDHATP53 (p53)TSC1
Atypical Teratoid Rhabdoid Tumors​
SMARCA4SMARCB1
Craniopharyngiomas​
BRAFCTNNB1
Ependymomas​
CDKN2A (P16INK4A)ERBB2 (HER-2, NEU)MEN1NF2TP53 (p53)
Ganglioneuromas​
ALKPHOX2B
Glioblastomas​
ALKAPCBCORBRAFBRCA2CDK4CDKN2A (P16INK4A)CDKN2B (p15INK4b)CREBBP (CBP)EGFR (ERBB1)EPCAMERBB2 (HER-2, NEU)IDH1KIT (CD117)LZTR1MLH1MSH2MSH6MTORMYCNRASPIK3CA (p110-alpha)PMS2PTENRB1TP53 (p53)
Gliomas​
ACVR1 (ALK2)ADGRB3ATRXBRAFBRCA2BRIP1CDKN2A (P16INK4A)CHD2CHEK2 (RAD53)CICEGFR (ERBB1)EP300FGFR1FLT1 (VEGFR1)H3-3AIDH1IRS2MDM4MYBMYCNNF1NSD2PDGFRAPIK3CA (p110-alpha)POT1PTENSTYK1TP53 (p53)
Hereditary Paraganglioma-Pheochromocytoma Syndrome​
MAXSDHAF2SDHBSDHCSDHDTMEM127
Intercranial Ependymomas​
CDKN2A (P16INK4A)CDKN2B (p15INK4b)
Lynch Syndrome​
EPCAMMLH1MSH2MSH6PMS2
Medulloblastomas​
ALPK2APCBRCA2CACNA1DCDH1 (E-Cadherin)CDK4CHD7CLTCL1CREBBP (CBP)CTCFCTNNB1DDX3XDDX60DEPDC5DICER1DNAH14DYNC1H1ERBB2 (HER-2, NEU)FAPFCRL2FGFR1GABRG1GPAMHDAC9IDH1IFIT3IRX2KAT6AKDM4CKDM6AKIF7KMT2BKMT2DLRRK1LRRK2MAST4MSH2MYCMYCNNCAPD3NLRP5NRASNRP1OTOFOTX2PARP2PCDHGB3PFKPPIK3CA (p110-alpha)PRKAG2PRLRPTCH1PTCH2PTENRAB11FIP1RB1SF3B1SMARCA4SMARCB1SUFUTP53 (p53)TPOTTNWDFY3WDFY4WRNZMYM3
Meningiomas​
CDKN2A (P16INK4A)CDKN2B (p15INK4b)G6PDMN1NF2PDGFBPTENSMARCE1SUFU
Neuroblastomas​
ALKBRCA1BRCA2DICER1EZH2HRASKIF1BNRASPHOX2BPTCH1PTPN11SMARCA4TP53 (p53)
Neurofibromas​
EPCAMMLH1MSH2MSH6NF1PMS2
Neurofibromatosis​
NF1NF2
Oligodendrogliomas​
CDKN2A (P16INK4A)CDKN2B (p15INK4b)IDH1MSH2RB1
Tuberous Sclerosis Complex​
TSC1TSC2
Other Central Nervous System Cancer Genes​
AIPCDKN1B (P27KIP1)EPHB2PRKAR1AVHL
Colorectal Cancers
Adenocarcinomas​
APCATMAXIN2BMPR1A (ALK3)BRAFBRCA1BRCA2CHEK2 (RAD53)EP300FLCNMLH1MLH3MSH2MSH3MSH6MUTYHNRASPALB2PMS1PMS2POLD1POLEPTENRNF43SMAD4 (MADH4)STK11 (LKB1)TGFBR2TP53 (p53)
Colorectal Cancer Susceptibility​
CCND1GALNT12POLD1POLESMAD7
Familial Adenomatous Polyposis​
APCMSH3MUTYHNTHL1POLD1POLE
Hereditary Mixed Polyposis Syndrome​
BMPR1A (ALK3)GREM1
Hereditary Nonpolyposis​
BRAFEPCAMMLH1MLH3MSH2MSH6PMS1PMS2TGFBR2
Hereditary Polyposis Syndrome​
BMPR1A (ALK3)GREM1
Juvenile Polyposis Syndrome​
BMPR1A (ALK3)SMAD4 (MADH4)
Lynch Syndrome​
BRAFEPCAMMLH1MLH3MSH2MSH6PMS1PMS2TGFBR2
Metastatic Colorectal Cancers​
ATMBRAFNRAS
Muir-Torre Syndrome​
MLH1MSH2
Other Colorectal Cancer Genes​
AURKABLMCDH1 (E-Cadherin)PKHD1PLA2G2ARB1RPS20SEMA4ATLR2XRCC2
Gastric Cancers
Gastrointestinal Stromal Tumors (GIST)​
KIT (CD117)NF1PDGFRASDHBSDHCSDHDTMEM127
Lynch Syndrome​
EPCAMMLH1MSH2MSH6PMS2
Multiple Endocrine Neoplasia​
CDKN1B (P27KIP1)MEN1
Other Gastric Cancer Genes​
APCATMBMPR1A (ALK3)CDH1 (E-Cadherin)CHEK2 (RAD53)CTNNA1KRASSMAD4 (MADH4)STK11 (LKB1)TP53 (p53)
Hematological Malignancies
Eosinophilia​
CR2JAK1
Lymphoproliferative Disorders​
PLAASH2D1AXIAP
Mastocytosis​
DNMT3AIDH2KIT (CD117)NRASRUNX1 (AML1)
Multiple Myeloma​
ATMCCND1IDH1IDH2KIT (CD117)LIG4NRASTP53 (p53)
Myelodysplastic Syndromes​
CEBPADNMT3AGATA2GNB1IDH1IDH2KIT (CD117)MPLMSH6NF1NRASRUNX1 (AML1)SMAD9TERCTERTTP53 (p53)
Myelofibrosis​
DNMT3AIDH1IDH2MPLNF1NRASTP53 (p53)
Myeloproliferative Neoplasms​
DNMT3AIDH1IDH2MPLRUNX1 (AML1)SH2B3TP53 (p53)
Polycythemia Vera​
DNMT3AIDH1NRASTP53 (p53)
Thrombocythemia​
IDH2MPLSH2B3THPOTP53 (p53)
Other Hematological Malignancies Genes​
BLMEPCAMHRASMLH1MSH2NBNPMS2
Hereditary Breast & Ovarian Cancers (HBOC)
Familial Breast-Ovarian Cancer Susceptibility​
BRCA1BRCA2FGFR2MAP3K1 (MEKK1)RAD51CRAD51DTOX3
Breast Cancer Carcinomas​
ATMBARD1BRCA1BRCA2BRIP1CHEK2 (RAD53)ERBB2 (HER-2, NEU)ESR1 (ERα)MLH1MSH2MSH6PALB2PIK3CA (p110-alpha)PMS2RAD51CRAD51D
Breast Cancer Ductal Carcinomas​
CDH1 (E-Cadherin)FGFR2MRE11NBNSTK11 (LKB1)TP53 (p53)
Breast Cancer Susceptibility​
BARD1BRCA2PALB2RECQLXRCC3
Metastatic Breast Cancers​
BRCA1BRCA2ERBB2 (HER-2, NEU)ESR1 (ERα)NF1PALB2PIK3CA (p110-alpha)PTEN
Other Breast Cancer Genes​
APCAXIN2SDHBSMARCA4TSHR
Ovarian Cancer Epithelial Carcinomas​
ABRAXAS1ATMBARD1BRCA1BRCA2BRIP1CHEK2 (RAD53)ERBB2 (HER-2, NEU)MRE11NBNNF1PALB2PIK3CA (p110-alpha)PTENRAD51CRAD51DTP53 (p53)
Ovarian Cancer Mixed Adenosquamous Carcinomas​
BLMCDH1 (E-Cadherin)DICER1FANCCFANCMFGFR2RAD50RAD51SMARCA4STK11 (LKB1)
Other Ovarian Cancer Genes​
MLH1RECQLRINT1XRCC2
Uterine Serous Carcinomas​
BLMCDH1 (E-Cadherin)DICER1FANCCFANCMFGFR2RAD50RAD51SMARCA4
Lynch Syndrome​
EPCAMMLH1MSH2MSH6PMS2
Other Hereditary Breast & Ovarian Cancer Genes​
HMMRMUTYHNQO2PGRPHBPOLD1PRKAR1A
Kidney Cancers
Hamartomas​
CDC73DIS3L2
Lynch Syndrome​
EPCAMMLH1MSH6PMS2
Nephroblastomas​
CDKN1C (p57Kip2)DIS3L2TRIM28
Papillary Renal Cell Carcinomas​
FHMET
Renal Cell Carcinomas​
BAP1BRAFFGFR3FHFLCNHNF1AHNF1BMETMITFMSH2MTORNRASPIK3CA (p110-alpha)PTENSDHASDHBSDHCSDHDTMEM127TP53 (p53)VHL
Rhabdoid Tumors​
SMARCA4SMARCB1
Tuberous Sclerosis Complex​
TSC1TSC2
Wilms Tumors​
BRAFBRCA2CDC73CDKN1C (p57Kip2)DICER1DIS3L2FZD6GPC3PAX6RESTVHLWT1
Other Kidney Cancer Genes​
BUB1B
Myeloid Neoplasms
Acute Lymphoblastic Leukemia (ALL)​
BRAFCDKN2A (P16INK4A)CDKN2B (p15INK4b)CREBBP (CBP)EP300ETV6EZH2FBXW7FLT3GATA3H2AC7H2BC6H2BC7H3C4H4C4IKZF1IKZF2IKZF3IL7RJAK1JAK2JAK3KRASMAPK1 (ERK2)NF1NOTCH1NRASPAG1PAX5PTENPTPN11RB1RUNX1 (AML1)SH2B3TP53 (p53)
Acute Megakaryoblastic Leukemia (AMKL)​
ERGGATA1JAK2METMPLOLIG2RUNX1 (AML1)SMOTMPRSS2
Acute Myeloid Leukemia (AML)​
BRCA2CEBPACHIC2DDX41DNMT3AETV6FLT3GATA1GATA2IDH1IDH2IKZF1IKZF2IKZF3JAK2KIT (CD117)KRASLPPMLLT10NRASPTPN11RB1RUNX1 (AML1)SH3GL1TERTTP53 (p53)WT1
Acute Promyelocytic Leukemia (APML; APL)​
CEBPARUNX1 (AML1)
Atypical Chronic Myeloid Leukemia (aCML)​
CBLCEBPAEZH2FLT3JAK2KRASNRASRUNX1 (AML1)SETBP1
B Cell Acute Lymphoblastic Leukemia (B-ALL)​
IKZF1JAK1JAK2PAX5
Chronic Lymphocytic Leukemia (CLL)​
BRAFGNB1NOTCH1NRASPTPN11TP53 (p53)
Chronic Myeloid Leukemia (CML)​
BRAFCBLCREBBP (CBP)DNMT3AEZH2IDH1IDH2IKZF1JAK2KRASNRASRUNX1 (AML1)TP53 (p53)WT1
Chronic Myelomonocytic Leukemia (CMML)​
CBLCEBPADNMT3AEZH2FLT3IDH1IDH2JAK2KIT (CD117)KRASMPLNF1NRASPHF6PTPN11RUNX1 (AML1)SETBP1TP53 (p53)
Early T-Cell Precursor Acute Lymphoblastic Leukemia​
BCL11BBRAFCDKN2A (P16INK4A)CDKN2B (p15INK4b)CTCFDCLRE1CDNM2ECT2LEEDEP300ETV6EZH2FBXW7FLT3GATA2GATA3H1-5HNRNPA1HNRNPRIKZF1IL7RJAK1JAK3KRASLEF1LMO2MYBNF1NOTCH1NRASPHF6PTENPTPN11RB1RELNRUNX1 (AML1)SETD2SH2B3SUZ12TAL1WT1
Hairy Cell Leukemia​
BRAFTP53 (p53)
Juvenile Myelomonocytic Leukemia​
CBLKRASNF1NRASPTPN11
T Cell Acute Lymphoblastic Leukemia (T-ALL)​
FBXW7NOTCH1
Other Leukemia Genes​
APCATMCDH1 (E-Cadherin)DICER1DNAJC21ERBB3ERCC2 (XPD)ERCC4KCNQ1MSH2MSH6MUTYHNBNNSD1RECQL4RETSOS1STK11 (LKB1)TSC2
Acute Lymphoblastic Lymphomas​
CDKN2A (P16INK4A)CDKN2B (p15INK4b)NOTCH1TP53 (p53)
B Cell Lymphomas​
BRAFCHEK2 (RAD53)EZH2TP53 (p53)
Follicular Lymphomas​
CREBBP (CBP)EP300EZH2
Non-Hodgkin Lymphomas​
BRAFNRASPIK3CA (p110-alpha)TP53 (p53)
T Cell Lymphomas​
ATMDNMT3AHAVCR2IDH1IDH2JAK1JAK3SETD2
Other Lymphoma Genes​
B2MBRCA2CEBPAKIT (CD117)KLHDC8BMSH2MSH6MUTYHPRF1PTPN11RB1RECQL4RETSTK11 (LKB1)TSC2
Myelodysplastic Syndromes​
CBLCEBPADDX41DNMT3AETV6EZH2FLT3GATA2GNB1IDH1IDH2JAK2JAK3KIT (CD117)KRASMPLNF1NRASPHF6PTPN11RUNX1 (AML1)SETBP1TERCTERTTP53 (p53)WT1
Myeloproliferative Neoplasms​
CBLDNMT3AEZH2IDH1IDH2JAK2MPLRUNX1 (AML1)SH2B3TP53 (p53)
Essential Thrombocythemia​
CBLIDH2JAK2MPLTP53 (p53)
Fanconi Anemia​
FANCAFANCBFANCD2FANCEFANCFFANCGFANCIFANCMSLX4
Mastocytosis​
CBLEZH2IDH2JAK2KIT (CD117)KRASNRASRUNX1 (AML1)
Multiple Myeloma​
ATMBRAFBRCA2CHEK2 (RAD53)FANCLIDH1IDH2KIT (CD117)KRASMETNRASRETTP53 (p53)
Polycythemia Vera​
DNMT3AEZH2IDH1JAK2NRASTP53 (p53)
Primary Myelofibrosis​
CBLDNMT3AEZH2IDH1IDH2JAK2MPLNF1NRASSETBP1TP53 (p53)
Systemic Mastocytosis​
CBLDNMT3AETV6EZH2IDH2JAK2KIT (CD117)KRASNRASRUNX1 (AML1)SETBP1
Pancreatic Cancers
Adenocarcinomas​
ATMBRCA1BRCA2CDKN2A (P16INK4A)CFTREPCAMFANCCMLH1MSH2MSH6PALB2PALLDPMS2PRSS1SMAD4 (MADH4)SPINK1STK11 (LKB1)TP53 (p53)
Adenomas​
TSC1TSC2
Familial Pancreatic Cancers​
ATMBRCA2CDKN2A (P16INK4A)PALB2
Hereditary Pancreatitis​
CFTRCTRCPRSS1PRSS2SPINK1
Lynch Syndrome​
EPCAMMLH1MSH2MSH6PMS2
Multiple Endocrine Neoplasia​
CDKN1B (P27KIP1)MEN1
Pancreatic Cancer Susceptibility​
BRCA1BRCA2PALB2PALLDRABL3
Other Pancreatic Cancer Genes​
APCBMPR1A (ALK3)CASRCDK4CPA1NF1VHL
Pediatric Cancers
Craniopharyngiomas​
APCSMARCA4SUFUTSC1
Embryonal Rhabdomyosarcomas​
CARD11CTNNB1FGFR4HRASKRASMDM2MDM4NF1NRASPIK3CA (p110-alpha)RARATP53 (p53)
Ependymomas​
MEN1NF2
Ewing's Sarcoma​
NF1RET
Germ Cell Tumors​
BRAFCBLFANCMPTEN
Hepatoblastomas​
CDK4MSH6TP53 (p53)
Hepatocellular Carcinomas​
APCCREBBP (CBP)CTNNB1IDH1KRASMETNRASPIK3CA (p110-alpha)TERTTP53 (p53)
Lynch Syndrome​
EPCAMMLH1PMS2
Nephroblastomas​
BRCA2CDKN1C (p57Kip2)DIS3L2PAX6POU6F2RESTSMARCB1WT1
Neuroblastomas​
ALKPHOX2BPTCH1
Osteosarcomas​
ATRXCDKN2A (P16INK4A)CHEK2 (RAD53)RB1RECQL4TP53 (p53)TSC2
Retinoblastomas​
APCCEBPAMAXRB1STK11 (LKB1)TSC2
Rhabdomyosarcomas​
BRCA1DICER1FOXO1MSH2PAX3PAX7
Other Pediatric Cancer Genes​
CDC73PRKAR1AVHL
Prostate Cancers
Adenocarcinomas​
ARBRIP1CHEK2 (RAD53)NBNPTENRAD51CRAD51DTP53 (p53)
Advanced Prostate Cancers​
ATMBRCA1BRCA2PALB2PTEN
Lynch Syndrome​
EPCAMMLH1MSH2MSH6PMS2
Other Prostate Cancer Genes​
CDH1 (E-Cadherin)EHBP1ELAC2HOXB13MSMBRNASEL
Skin Cancers
Cutaneous Melanomas​
BAP1CDK4CDKN2A (P16INK4A)MC1RMITFPOT1XRCC3
Malignant Melanoma Susceptibility​
CDK4CDKN2A (P16INK4A)MC1RMITFPOT1TERTXRCC3
Malignant Melanomas​
CDK4CDKN2A (P16INK4A)MC1RMITFPOT1XRCC3
Melanomas​
BRAFBRCA1BRCA2CDK4CDKN2A (P16INK4A)CDKN2B-AS1CREBBP (CBP)IDH1KIT (CD117)KRASMAP2K1MAP2K2 (MEK2)MC1RMITFNRASPIK3CA (p110-alpha)POT1PTENRAF1RB1TERTTP53 (p53)TYR
Uveal Melanomas​
BAP1BRCA2CDKN2A (P16INK4A)CDKN2B (p15INK4b)
Xeroderma Pigmentosum​
DDB2ERCC2 (XPD)ERCC3 (XPB)ERCC4ERCC5POLHXPAXPC
Other Skin Cancer Genes​
ATRCYLDFHFLCNPRKAR1APTCH2

Resources

Application Notes (1)
Kit Handbooks (2)
For ultrasensitive targeted next-generation sequencing of DNA for Ion Torrent NGS systems
For ultrasensitive targeted next-generation sequencing (NGS) of DNA for Illumina NGS systems
Safety Data Sheets (1)
Certificates of Analysis (1)
Template Files (1)
icon_0071_person-s

Do you want to create a custom panel or to boost an existing one?

 

Introducing the QIAseq Targeted DNA Pro Human Comprehensive Hereditary Cancer Research Panel, a cutting-edge addition to our QIAseq Targeted DNA Pro Panels lineup, specifically designed for NGS applications. This premium product offers unparalleled performance for researchers working with Human models. Leveraging advanced technology, the QIAseq Targeted DNA Pro Human Comprehensive Hereditary Cancer Research Panel facilitates accurate and reliable results, making it an indispensable tool for your scientific investigations. Whether you're conducting NGS, or any other sophisticated analyses, this product from our QIAseq Targeted DNA Pro Panels collection ensures optimal efficiency and reproducibility for Human studies. Embrace the future of research with QIAseq Targeted DNA Pro Human Comprehensive Hereditary Cancer Research Panel and elevate your work to new heights.